Related Experiment Video
Updated: Aug 9, 2026
08:15
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
[Sexual dysfunctions induced by antidepressive agents]
Krzysztof Kucia1, Robert S Delkowski
1Katedry i Kliniki Psychiatrii i Psychoterapii Slaskiej Akademii Medycznej w Katowicach.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|April 6, 2006
Summary
Sexual dysfunctions can be a symptom of depression or a side effect of antidepressant medications. This article explains how antidepressants affect sexual function and suggests management strategies for these common issues.
Area of Science:
- Pharmacology and Neuroscience
- Clinical Psychology and Psychiatry
Context:
- Sexual dysfunction is a prevalent issue, often linked to depressive disorders.
- Antidepressant medications, while crucial for mental health, can induce sexual side effects.
Purpose:
- To elucidate the pathophysiological mechanisms underlying antidepressant-induced sexual dysfunction.
- To detail the impact of antidepressants on distinct phases of the sexual response cycle.
- To outline therapeutic strategies for managing sexual dysfunction in patients using antidepressants.
Summary:
- This review explores the intricate relationship between antidepressant use and sexual dysfunction.
- It details how various antidepressants interfere with neurobiological pathways governing sexual function.
- Management approaches are discussed, emphasizing that spontaneous resolution of these dysfunctions is uncommon.
Impact:
- Provides clinicians with a deeper understanding of sexual side effects associated with antidepressant therapy.
- Offers practical guidance for managing and mitigating sexual dysfunction, improving patient adherence and quality of life.
- Highlights the need for proactive assessment and intervention for sexual health in patients undergoing psychiatric treatment.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
01:27Depressive Disorders: MDD and Dysthymia
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.